维普中文期刊产品整合服务
14篇 您的检索式:作者名="Maria PM"
    题名 作者 年代 出处 被引量
1Surgical options for malignant left-sided colonic obstruction显示文摘Jesus MV Ana PM Maria TV 2005Surg Today2005,35,:1
2Novel antifungal tetracyclic compounds from Bauhinia rufescens LAMK 显示文摘Mare PM Maria Carmen PI Mahamane S 1991Helvetica Chimica Acta1991,74,:1
3Novel antifungal tetracyclic compounds from Bauhinia rufescens LAMK显示文摘 Maria Carmen PI Maharnane S 1991Helvetica Chimica Acta1991,74,:1
4Novel antifungal tetracyclic compounds from Bauhinia rufescens LAMK显示文摘 Maria Carmen PI M ahamane S 1991Helvetica Chimica Acta1991,74,:1
5Determination and valida- tion of dietary fiber in food by the enzymatic gravimetric method显示文摘Maria LG Deiseap PM Elizabetha FST 2003Food Chem2003,83,3:1
6Timecourse of osmoregulatory and metabolic changesduring osmotic acclimation in Sparus auratus 显示文摘Susana S A Francisco J A Maria PM R 2005The Journal of Experimental Biology2005,208,:1
7Microcalcifica- tians associaled with breast cancer:An epiphenomenon or biologically significant feature of selected tumor 显示文摘Maria PM Miehehe MCC Eratdine MM 2005Journal of Mammary Gland Biology and Neoplasia2005,10,2:1
8Assessment of myocardial Viability in patients with postischemic left ventricular dysfunction : role of myocardial contrast echocardiography 显示文摘Luciano AI Francesca DM Maria PM 2003Echocardiography2003,20,1:1
9Helping relationship kkills in nurses: the validation of a measurement instrument 显示文摘Rosa PM Maria JS Miguel DP 2011Rev Esc Enferm USP2011,45,6:1
10Assessment of myocardial viability in patients with postischemic left ventricular dysfunction:role of myocardial contrast echocardiography显示文摘Luciano AI Francesca DM Maria PM 2003Echocardiography2003,20,:1
11MicrocaIcifications as-sociated with breast cancer:An epiphenomenon or biologically significant feature of selected tumors显示文摘Maria PM Michelle MC Geraldine MM 2005Journal of Mammary Gland Biology and Neoplasia2005,10,2:1
12In Vitro Evaluation of Apical Sealing in Root Apex Treated with Demineralization Agents and Retrofiled with Mineral Trioxide Aggregate Through Marginal Dye Leakage 显示文摘Claudio H Ana PM Maria NG 2005Braz Dent J2005,16,3:1
13Effect of soy protein supplementation in patients with chronic hepatitis C:A randomized clinical trial显示文摘AIM:To evaluate the effects of soy supplementation on insulin resistance,fatty liver and alanine aminotransferase(ALT) levels in non-diabetic patients with chronic hepatitis C(CHC).METHODS:In a prospective,randomized and singleblinded clinical trial,we compared patients with CHC who had casein as a supplement(n = 80)(control group),with patients who consumed a soy supplement diet(n = 80) [intervention group(IG)].Both groups received 32 g/d of protein for 12 wk.RESULTS:Patients' baseline features showed that 48.1% were overweight,43.7% had abdominal fat accumulation,34.7% had hepatic steatosis and 36.3% had an homeostasis model assessment index of insulin resistance(HOMA-IR) ≥ 3.0.Descriptive analysis showed that protein supplementation diet reduced hepatic steatosis in both groups;however,significant reductions in ALT levels occurred in the soy group.Multiple regression modeling indicated that in the presence of severe fibrosis(F3/F4),g glutamyl transferase elevation and high density lipoprotein(HDL) reduction,the intervention group had 75% less chance of developing hepatic steatosis(OR= 0.25;95% CI:0.06-0.82) and 55% less chance of presenting with an ALT level ≥ 1.5 × the upper limit of normal(ULN)(OR = 0.45,95% CI:0.22-0.89).Soy treatment did not have any effect on insulin resistance(OR = 1.92;95% CI:0.80-4.83),which might be attributed to the fact that the HOMAIR values at baseline in most of our patients were in the normal range.Advanced hepatic fibrosis,an ALT level > 1.5 × ULN and visceral fat were predictors of an HOMA-IR ≥ 3.The IG group had a reduced risk of an ALT level > 1.5 × ULN.An HOMA-IR ≥ 3.0 and HDL < 35 mg/dL were also risk factors for increased ALT.CONCLUSION:Soy supplementation decreased ALT levels and thus may improve liver inflammation in hepatitis C virus(HCV) patients;it also reduced hepatic steatosis in a subgroup of patients but did not change insulin resistance.It should be considered in the nutritional care of HCV patients.Lucivalda PM Oliveira Rosangela P de Jesus Ramona SSB Boulhosa Carlos Mauricio C Mendes Maria Cecilia Gnoatto Denise C Lemaire Maria Betania P Toralles Lourianne N Cavalcante Andre C Lyra Luiz GC Lyra 2012World Journal of Gastroenterology2012,18,18:1
14Synthesis and biological evaluatioll of aryl azide derivatives of Combretastatin A-4 as molecular probes for tubulin 显示文摘Kevin GP Maria PM Victor MV 2000Bioorg Med Chem Lett2000,8,21:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费